[1]
|
刘正, 邵子玮, 袁文华, 等. Eph/ephrin信号通路与神经干细胞的增殖和分化[J] 中国组织工程研究, 2019, 23(13): 2101-2106.
|
[2]
|
Hirai, H., Maru, Y., Hagiwara, K., et al. (1987) A Novel Putative Tyrosine Kinase Receptor Encoded by the eph Gene. Science, 238, 1717-1720. https://doi.org/10.1126/science.2825356
|
[3]
|
Papadakos, S.P., Dedes, N., Gkolemi, N., Machairas, N. and Theocharis, S. (2023) The EPH/Ephrin System in Pancreatic Ductal Adenocarcino-ma (PDAC): From Pathogenesis to Treatment. International Journal of Molecular Sciences, 24, Article 3015. https://doi.org/10.3390/ijms24033015
|
[4]
|
Sahoo, A.R. and Buck, M. (2021) Structural and Functional Insights into the Transmembrane Domain Association of Eph Receptors. International Journal of Molecular Sciences, 22, Article 8593. https://doi.org/10.3390/ijms22168593
|
[5]
|
Pasquale, E.B. (2005) Eph Receptor Signalling Casts a Wide Net on Cell Behaviour. Nature Reviews Molecular Cell Biology, 6, 462-475. https://doi.org/10.1038/nrm1662
|
[6]
|
De Boer, E.C.W., van Gils, J.M. and van Gils, M.J. (2020) Ephrin-Eph Signaling Usage by a Variety of Viruses. Pharma-cological Research, 159, Article ID: 105038. https://doi.org/10.1016/j.phrs.2020.105038
|
[7]
|
Xiao, T., Xiao, Y., Wang, W., et al. (2020) Targeting EphA2 in Cancer. Journal of Hematology & Oncology, 13, Article No. 114. https://doi.org/10.1186/s13045-020-00944-9
|
[8]
|
Liang, L.Y., Patel, O., Janes, P.W., Murphy, J.M. and Lucet, I.S. (2019) Eph Receptor Signalling: From Catalytic to Non-Catalytic Functions. Oncogene, 38, 6567-6584. https://doi.org/10.1038/s41388-019-0931-2
|
[9]
|
Shiuan, E. and Chen, J. (2016) Eph Receptor Tyrosine Kinases in Tumor Immunity. Cancer Research, 76, 6452-6457.
https://doi.org/10.1158/0008-5472.CAN-16-1521
|
[10]
|
Darling, T.K. and Lamb, T.J. (2019) Emerging Roles for Eph Receptors and Ephrin Ligands in Immunity. Frontiers in Immunology, 10, Article 1473. https://doi.org/10.3389/fimmu.2019.01473
|
[11]
|
Janes, P.W., Vail, M.E., Ernst, M. and Scott, A.M. (2021) Eph Receptors in the Immunosuppressive Tumor Microenvironment. Cancer Research, 81, 801-805. https://doi.org/10.1158/0008-5472.CAN-20-3047
|
[12]
|
Alonso, C.L., Trinidad, E.M., de Garcillan, B., et al. (2009) Expression Profile of Eph Receptors and Ephrin Ligands in Healthy Human B Lymphocytes and Chronic Lymphocytic Leukemia B-Cells. Leukemia Research, 33, 395-406.
https://doi.org/10.1016/j.leukres.2008.08.010
|
[13]
|
Jellinghaus, S., Poitz, D.M., Ende, G., et al. (2013) Ephrin-A1/EphA4-Mediated Adhesion of Monocytes to Endothelial Cells. Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, 1833, 2201-2211.
https://doi.org/10.1016/j.bbamcr.2013.05.017
|
[14]
|
Pfaff, D., Héroult, M., Riedel, M., et al. (2008) Involvement of Endothelial Ephrin-B2 in Adhesion and Transmigration of EphB-Receptor-Expressing Monocytes. Journal of Cell Sci-ence, 121, 3842-3850. https://doi.org/10.1242/jcs.030627
|
[15]
|
Ivanov, A.I. and Romanovsky, A.A. (2006) Puta-tive Dual Role of Ephrin-Eph Receptor Interactions in Inflammation. IUBMB Life, 58, 389-394. https://doi.org/10.1080/15216540600756004
|
[16]
|
Muñoz, J.J., Cejalvo, T., Alonso-Colmenar, L.M., et al. (2011) Eph/Ephrin-Mediated Interactions in the Thymus. Neuroimmunomodulation, 18, 271-280. https://doi.org/10.1159/000329490
|
[17]
|
Alfaro, D., García-Ceca, J.J., Cejalvo, T., et al. (2007) EphrinB1-EphB Signaling Regulates Thymocyte-Epithelium Interactions Involved in Functional T Cell Development. European Journal of Immunology, 37, 2596-2605.
https://doi.org/10.1002/eji.200737097
|
[18]
|
Muñoz, J.J., Alfaro, D., García-Ceca, J., et al. (2006) Thymic Altera-tions in EphA4-Deficient Mice. The Journal of Immunology, 177, 804-813. https://doi.org/10.4049/jimmunol.177.2.804
|
[19]
|
Sharfe, N., Nikolic, M., Cimpeon, L., et al. (2008) EphA and Ephrin-A Proteins Regulate Integrin-Mediated T Lymphocyte Interactions. Molecular Immunology, 45, 1208-1220. https://doi.org/10.1016/j.molimm.2007.09.019
|
[20]
|
Diegelmann, R.F. and Evans, M.C. (2004) Wound Healing: An Overview of Acute, Fibrotic and Delayed Healing. Frontiers in Bioscience, 9, 283-289. https://doi.org/10.2741/1184
|
[21]
|
Coulthard, M.G., Morgan, M., Woodruff, T.M., et al. (2012) Eph/Ephrin Sig-naling in Injury and Inflammation. The American Journal of Pathology, 181, 1493-1503. https://doi.org/10.1016/j.ajpath.2012.06.043
|
[22]
|
Fabes, J., Anderson, P., Brennan, C. and Bolsover, S. (2007) Regeneration-Enhancing Effects of EphA4 Blocking Peptide Following Corticospinal Tract Injury in Adult Rat Spinal Cord. European Journal of Neuroscience, 26, 2496-2505.
https://doi.org/10.1111/j.1460-9568.2007.05859.x
|
[23]
|
Carmichael, S.T. (2003) Gene Expression Changes after Focal Stroke, Traumatic Brain and Spinal Cord Injuries. Current Opinion in Neurology, 16, 699-704. https://doi.org/10.1097/00019052-200312000-00009
|
[24]
|
Hong, J.Y., et al. (2015) EphA2 Receptor Signaling Mediates Inflammatory Responses in Lipopolysaccharide-Induced Lung Injury. Tuberculosis and Respiratory Diseases, 78, 218-226. https://doi.org/10.4046/trd.2015.78.3.218
|
[25]
|
Kaplan, N., et al. (2012) EphA2/Ephrin-A1 Signaling Complexes Restrict Corneal Epithelial Cell Migration. Investigative Ophthalmology & Visual Science, 53, 936-945. https://doi.org/10.1167/iovs.11-8685
|
[26]
|
Wijeratne, D., et al. (2019) Ephrin-A2 Affects Wound Healing and Scar-ring in a Murine Model of Excisional Injury. Burns, 45, 682-690. https://doi.org/10.1016/j.burns.2018.10.002
|
[27]
|
Cheng, N., Brantley, D.M. and Chen, J. (2002) The Ephrins and Eph Receptors in Angiogenesis. Cytokine & Growth Factor Reviews, 13, 75-85. https://doi.org/10.1016/S1359-6101(01)00031-4
|
[28]
|
Larson, J., Schomberg, S., Schroeder, W., and Carpenter, T.C. (2008) Endothelial EphA Receptor Stimulation Increases Lung Vascular Permeability. American Journal of Physi-ology-Lung Cellular and Molecular Physiology, 295, L431-L439.
https://doi.org/10.1152/ajplung.90256.2008
|
[29]
|
Cercone, M.A., Schroeder, W., Schomberg, S., et al. (2009) EphA2 Receptor Mediates Increased Vascular Permeability in Lung Injury due to Viral Infection and Hypoxia. American Journal of Physiology-Lung Cellular and Molecular Physiology, 297, L856-L863. https://doi.org/10.1152/ajplung.00118.2009
|
[30]
|
Kuijper, S., Turner, C.J. and Adams, R.H. (2007) Regulation of Angiogenesis by Eph-Ephrin Interactions. Trends in Cardiovascular Medicine, 17, 145-151. https://doi.org/10.1016/j.tcm.2007.03.003
|
[31]
|
Stephen, L.J., Fawkes, A.L., Verhoeve, A., Lemke, G. and Brown, A. (2007) A Critical Role for the EphA3 Receptor Tyrosine Kinase in Heart Development. Developmental Biology, 302, 66-79.
https://doi.org/10.1016/j.ydbio.2006.08.058
|
[32]
|
Frieden, L.A., et al. (2010) Regulation of Heart Valve Morpho-genesis by Eph Receptor Ligand, Ephrin-A1. Developmental Dynamics, 239, 3226-3234. https://doi.org/10.1002/dvdy.22458
|
[33]
|
Salvucci, O. and Tosato, G. (2012) Essential Roles of EphB Receptors and EphrinB Ligands in Endothelial Cell Function and Angiogenesis. Advances in Cancer Research, 114, 21-57.
https://doi.org/10.1016/B978-0-12-386503-8.00002-8
|
[34]
|
Barquilla, A. and Pasquale, E.B. (2015) Eph Receptors and Ephrins: Therapeutic Opportunities. Annual Review of Pharmacology and Toxicology, 55, 465-487. https://doi.org/10.1146/annurev-pharmtox-011112-140226
|
[35]
|
Wu, Z.H., et al. (2012) Possible Role of Efnb1 Protein, a Ligand of Eph Receptor Tyrosine Kinases, in Modulating Blood Pressure. Journal of Biological Chemistry, 287, 15557-15569. https://doi.org/10.1074/jbc.M112.340869
|
[36]
|
Pasquale, E.B. (2010) Eph Receptors and Ephrins in Cancer: Bidirectional Signalling and beyond. Nature Reviews Cancer, 10, 165-180. https://doi.org/10.1038/nrc2806
|
[37]
|
Miao, H. and Wang, B.C. (2012) EphA Receptor Signaling—Complexity and Emerging Themes. Seminars in Cell & Developmental Biology, 23, 16-25. https://doi.org/10.1016/j.semcdb.2011.10.013
|
[38]
|
Nishimura, M., et al. (2013) Therapeutic Synergy between mi-croRNA and siRNA in Ovarian Cancer Treatment. Cancer Discovery, 3, 1302-1315. https://doi.org/10.1158/2159-8290.CD-13-0159
|
[39]
|
Arvanitis, D.N. and Davy, A. (2012) Regulation and Misreg-ulation of Eph/Ephrin Expression. Cell Adhesion & Migration, 6, 131-137. https://doi.org/10.4161/cam.19690
|
[40]
|
Lisabeth, E.M., Fernandez, C. and Pasquale, E.B. (2012) Cancer Somatic Mutations Disrupt Functions of the EphA3 Receptor Tyrosine Kinase through Multiple Mechanisms. Biochemistry, 51, 1464-1475.
https://doi.org/10.1021/bi2014079
|
[41]
|
Zhuang, G.L., et al. (2012) Effects of Cancer-Associated EPHA3 Muta-tions on Lung Cancer. Journal of the National Cancer Institute, 104, 1183-1198. https://doi.org/10.1093/jnci/djs297
|
[42]
|
Gökmen-Polar, Y., et al. (2011) Dual Targeting of EphA2 and ER Restores Tamoxifen Sensitivity in ER/EphA2-Positive Breast Cancer. Breast Cancer Research and Treatment, 127, 375-384. https://doi.org/10.1007/s10549-010-1004-y
|
[43]
|
Zhuang, G.L., et al. (2010) Elevation of Receptor Tyrosine Kinase EphA2 Mediates Resistance to Trastuzumab Therapy. Cancer Research, 70, 299-308. https://doi.org/10.1158/0008-5472.CAN-09-1845
|
[44]
|
Li, J.L., et al. (2011) DLL4-Notch Signaling Mediates Tu-mor Resistance to Anti-VEGF Therapy in vivo. Cancer Research, 71, 6073-9083. https://doi.org/10.1158/0008-5472.CAN-11-1704
|
[45]
|
Yamaguchi, Y. and Pasquale, E.B. (2004) Eph Receptors in the Adult Brain. Current Opinion in Neurobiology, 14, 288-296. https://doi.org/10.1016/j.conb.2004.04.003
|
[46]
|
Pasquale, E.B. (2008) Eph-Ephrin Bidirectional Signaling in Physiology and Disease. Cell, 133, 38-52.
https://doi.org/10.1016/j.cell.2008.03.011
|
[47]
|
Hruska, M. and Dalva, M.B. (2012) Ephrin Regulation of Synapse Formation, Function and Plasticity. Molecular and Cellular Neuroscience, 50, 35-44. https://doi.org/10.1016/j.mcn.2012.03.004
|
[48]
|
Holmberg, J., Clarke, D.L. and Frisén, J. (2000) Regulation of Re-pulsion versus Adhesion by Different Splice Forms of an Eph Receptor. Nature, 408, 203-206. https://doi.org/10.1038/35041577
|
[49]
|
Ji, Y.J., et al. (2014) EphrinB2 Affects Apical Constriction in Xenopus Embryos and Is Regulated by ADAM10 and Flotillin-1. Nature Communications, 5, Article No. 3516. https://doi.org/10.1038/ncomms4516
|
[50]
|
Depaepe, V., et al. (2005) Ephrin Signalling Controls Brain Size by Regulating Apoptosis of Neural Progenitors. Nature, 435, 1244-1250. https://doi.org/10.1038/nature03651
|
[51]
|
Arvanitis, D.N., et al. (2013) Ephrin B1 Maintains Apical Adhesion of Neural Progenitors. Development, 140, 2082-2092.
https://doi.org/10.1242/dev.088203
|
[52]
|
Feng, G., et al. (2000) Roles for Ephrins in Positionally Selective Synap-togenesis between Motor Neurons and Muscle Fibers. Neuron, 25, 295-306. https://doi.org/10.1016/S0896-6273(00)80895-8
|
[53]
|
Kayser, M.S., Nolt, M.J. and Dalva, M.B. (2008) EphB Re-ceptors Couple Dendritic Filopodia Motility to Synapse Formation. Neuron, 59, 56-69. https://doi.org/10.1016/j.neuron.2008.05.007
|
[54]
|
Clifford, M.A., et al. (2014) EphA7 Signaling Guides Cortical Dendritic Development and Spine Maturation. Proceedings of the National Academy of Sciences of the United States of America, 111, 4994-4999.
https://doi.org/10.1073/pnas.1323793111
|
[55]
|
Du, J., Fu, C. and Sretavan, D.W. (2007) Eph/Ephrin Signaling as a Potential Therapeutic Target after Central Nervous System Injury. Current Pharmaceutical Design, 13, 2507-2518. https://doi.org/10.2174/138161207781368594
|
[56]
|
Kempf, A., et al. (2013) Upregulation of Axon Guidance Mol-ecules in the Adult Central Nervous System of Nogo—A Knockout Mice Restricts Neuronal Growth and Regeneration. European Journal of Neuroscience, 38, 3567-3579.
https://doi.org/10.1111/ejn.12357
|
[57]
|
Goldshmit, Y., et al. (2011) EphA4 Blockers Promote Axonal Regeneration and Functional Recovery Following Spinal Cord Injury in Mice. PLOS ONE, 6, e24636. https://doi.org/10.1371/journal.pone.0024636
|
[58]
|
Van Hoecke, A., et al. (2012) EPHA4 Is a Disease Modifier of Amyotrophic Lateral Sclerosis in Animal Models and in Humans. Nature Medicine, 18, 1418-1422. https://doi.org/10.1038/nm.2901
|
[59]
|
Lin, S., Wang, B. and Getsios, S. (2012) Eph/Ephrin Signaling in Epidermal Differentiation and Disease. Seminars in Cell & Developmental Biology, 23, 92-101. https://doi.org/10.1016/j.semcdb.2011.10.017
|
[60]
|
Gordon, K., Kochkodan, J.J., Blatt, H., et al. (2013) Alteration of the EphA2/Ephrin—A Signaling Axis in Psoriatic Epidermis. Journal of Investigative Dermatology, 133, 712-722. https://doi.org/10.1038/jid.2012.391
|
[61]
|
Genander, M., Holmberg, J. and Frisén, J. (2010) Ephrins Negatively Regulate Cell Proliferation in the Epidermis and Hair Follicle. Stem Cells, 28, 1196-1205. https://doi.org/10.1002/stem.442
|
[62]
|
Zhao, C., (2006) Bidirectional Ephrinb2-EphB4 Signaling Controls Bone Homeostasis. Cell Metabolism, 4, 111-121.
https://doi.org/10.1016/j.cmet.2006.05.012
|
[63]
|
Cheng, S.H., et al. (2012) Targeted Disruption of Ephrin B1 in Cells of Myeloid Lineage Increases Osteoclast Differentiation and Bone Resorption in Mice. PLOS ONE, 7, e32887. https://doi.org/10.1371/journal.pone.0032887
|
[64]
|
Szepietowska, B., Zhu, W.L., Czyzyk, J., Eid, T. and Sherwin, R.S. (2013) EphA5-EphrinA5 Interactions within the Ventromedial Hypothalamus Influence Counterregulatory Hormone Release and Local Glutamine/Glutamate Balance during Hypoglycemia. Diabetes, 62, 1282-1288. https://doi.org/10.2337/db12-0982
|
[65]
|
Jain, R., et al. (2013) Pharmacological Inhibition of Eph Receptors En-hances Glucose-Stimulated Insulin Secretion from Mouse and Human Pancreatic Islets. Diabetologia, 56, 1350-1355. https://doi.org/10.1007/s00125-013-2877-1
|